FILE:JNJ/JNJ-8K-20110614171238.txt.gz
EVENTS:	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers	Financial Statements and Exhibits
TEXT:
ITEM: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM: Financial Statements and Exhibits
 
 
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
           Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o
           Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o
           Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o
           Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
o
 
 
 
 
 
 
 
Item 5.02.  Departure of Directors of Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements for Certain Officers.
As a non-employee director of the Company, Mr. Williams receives compensation as described in the "Executive and Director Compensation" section of the Company's 2011 Proxy Statement.  As part of that compensation, Mr. Williams received a one-time grant of 1,000 shares of unrestricted Common Stock at $67.06 per share upon becoming a member of the Company's Board of Directors.  The Companys press release announcing the appointment is attached to this Report as Exhibit 99.1.
On June 13, 2011, Ronald A. Williams, former Chairman and Chief Executive Officer of Aetna Inc., was appointed to the Board of Directors of Johnson & Johnson.  Mr. Williams was named to the Compensation & Benefits Committee and the Public Policy Advisory Committee of the Board.  
Item 9.01.  Financial Statements and Exhibits
(d) Exhibits.
99.1  Press release dated June 14, 2011.
 
 
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Exhibit 99.1
For Immediate Release


